209 related articles for article (PubMed ID: 33468247)
1. Impact of multiple policy interventions on the screening and diagnosis of drug-resistant tuberculosis patients: a cascade analysis on six prefectures in China.
Ding XY; Mao WH; Lu W; Yu H; Liu Q; Lu P; Jiang H; Zhang X; Lu F; Xu J; Zhong CQ; Hu JL; Jiang WX; Guo L; Tang SL; Zhu LM
Infect Dis Poverty; 2021 Jan; 10(1):8. PubMed ID: 33468247
[TBL] [Abstract][Full Text] [Related]
2. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
[TBL] [Abstract][Full Text] [Related]
3. Access to quality diagnosis and rational treatment for tuberculosis: real-world evidence from China-Gates Tuberculosis Control Project Phase III.
Li ZP; Mao WH; Huang F; Wang N; Ma LP; Zhang LQ; Gao MQ; Wang WB; Zhao Q; Tang SL
Infect Dis Poverty; 2021 Jun; 10(1):92. PubMed ID: 34187558
[TBL] [Abstract][Full Text] [Related]
4. Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam.
Hoang TT; Nguyen NV; Dinh SN; Nguyen HB; Cobelens F; Thwaites G; Nguyen HT; Nguyen AT; Wright P; Wertheim HF
BMC Public Health; 2015 Sep; 15():980. PubMed ID: 26415893
[TBL] [Abstract][Full Text] [Related]
5. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
Qi W; Harries AD; Hinderaker SG
Int J Tuberc Lung Dis; 2011 Jan; 15(1):137-9. PubMed ID: 21276311
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the GenoType(®) MTBDRplus line probe assay on sputum-positive samples in routine settings in China.
Chen C; Kong W; Zhu L; Zhou Y; Peng H; Shao Y; Song H; Liu Q; Li G; Shi J; Zhong C; Zhu L; Ding X; Yu H; Yang H; Lu W
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1034-9. PubMed ID: 25189549
[TBL] [Abstract][Full Text] [Related]
7. [Tuberculosis in Asia].
Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
[TBL] [Abstract][Full Text] [Related]
8. The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership.
Wang L; Li R; Xu C; Zhang H; Ruan Y; Chen M; Wang D; Dirlikov E; Du X; Zhao J; Zhao Y; Wang S; Liu Y; Li L; Falzon D; Sun Y; Wang Y; Schwartländer B; Scano F
PLoS One; 2017; 12(6):e0177536. PubMed ID: 28628669
[TBL] [Abstract][Full Text] [Related]
9. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study.
Li Q; Ou XC; Pang Y; Xia H; Huang HR; Zhao B; Wang SF; Zhao YL
Tuberculosis (Edinb); 2017 Jul; 105():9-12. PubMed ID: 28610793
[TBL] [Abstract][Full Text] [Related]
10. High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis.
Yang Z; Zhou C; Ning Z; Lu W; Zhao Q; Hu Y; Diwan VK; Xu B
Glob Health Action; 2018; 11(1):1500763. PubMed ID: 30203719
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of rifampicin-resistant tuberculosis detection in China, 2015-2019.
Su W; Ruan YZ; Li T; Du X; Jiang JW; Li RZ
Infect Dis Poverty; 2021 Jul; 10(1):99. PubMed ID: 34274020
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China.
Liu Z; Pan A; Wu B; Zhou L; He H; Meng Q; Chen S; Pang Y; Wang X
Trop Med Int Health; 2017 Oct; 22(10):1328-1333. PubMed ID: 28746979
[TBL] [Abstract][Full Text] [Related]
13. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.
Shi W; Davies Forsman L; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
Int J Infect Dis; 2020 Jul; 96():390-397. PubMed ID: 32353546
[TBL] [Abstract][Full Text] [Related]
14. Impacts of a comprehensive tuberculosis control model on the quality of clinical services and the financial burden of treatment for patients with drug-resistant tuberculosis in China: a mixed-methods evaluation.
Jiang WX; Li ZP; Zhao Q; Gao MQ; Long Q; Wang WB; Huang F; Wang N; Tang SL
Infect Dis Poverty; 2021 Apr; 10(1):54. PubMed ID: 33883030
[TBL] [Abstract][Full Text] [Related]
15. Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear-Negative Drug-Resistant Tuberculosis, China.
Huang F; van den Hof S; Qu Y; Li Y; Zhang H; Wang L; Sun M; Lu W; Hou S; Zhang T; Huan S; Chin DP; Cobelens F
Emerg Infect Dis; 2019 Jul; 25(7):1289-1296. PubMed ID: 31211666
[TBL] [Abstract][Full Text] [Related]
16. Rapid Screening of MDR-TB in Cases of Extra Pulmonary Tuberculosis Using Geno Type MTBDRplus.
Kumari R; Tripathi R; Pandey AP; Banerjee T; Sinha P; Anupurba S
PLoS One; 2016; 11(7):e0159651. PubMed ID: 27441660
[TBL] [Abstract][Full Text] [Related]
17. Is deployement of diagnostic test alone enough? Comprehensive package of interventions to strengthen TB laboratory network: three years of experience in Burkina Faso.
Alagna R; Combary A; Tagliani E; Sawadogo LT; Saouadogo T; Diandé S; Ouedraogo F; Cirillo DM
BMC Infect Dis; 2021 Apr; 21(1):346. PubMed ID: 33849486
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
[TBL] [Abstract][Full Text] [Related]
19. Detection of multidrug-resistant tuberculosis using MGIT™(TM) and MAS-PCR in Tripura, India.
Majumdar T; Bhattacharya S; Barman D; Bhoumik P; Bir R
Int J Tuberc Lung Dis; 2016 Feb; 20(2):166-9. PubMed ID: 26792467
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
